NNovo Nordisk Read More Novo Holdings to Invest 100 Billion Won in Korean Biohealth Sector2026-04-27 Wegovy product photo. Photo courtesy of Novo Nordisk Novo Holdings, the parent company of Danish pharmaceutical firm Novo…
NNovo Nordisk Read More Novo Nordisk’s Oral Wegovy Pill Leaves Eli Lilly in the Dust as Pipeline Battles Loom2026-04-25 Novo Nordisk shares jump 6.4% as oral Wegovy prescriptions dwarf Eli Lilly’s rival, while pivotal CagriSema trial data…
NNovo Nordisk Read More Med Ad News 2026 Marketer on the Rise: Dipa Sapre2026-04-24 Dipa Sapre, director of HCP obesity strategy & marketing, Novo Nordisk Med Ad News 2026 Marketer on the…
NNovo Nordisk Read More Eurofarma and Novo Nordisk team up to fight the slimming pen war.2026-04-20 The patent for semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy slimming pens, expired in Brazil…
NNovo Nordisk Read More Novo Nordisk Bets on AI and Subscriptions to Counter a Steep Slide2026-04-19 Novo Nordisk shares surge as the firm partners with OpenAI to accelerate drug development and expands Wegovy subscription…
NNovo Nordisk Read More Novo Nordisk’s Wegovy Wins EMA Flexibility In GLP-1 Access Push2026-04-17 Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
NNovo Nordisk Read More Eli Lilly’s Foundayo And Novo Nordisk’s Wegovy – A Look At Some Key Highlights2026-04-17 Lilly just announced positive results from its Phase 3 ACHIEVE-4 trial, boosting confidence in its experimental diabetes pill,…
NNovo Nordisk Read More Novo Nordisk’s Buyback and Subscription Push Amidst Revenue Headwinds2026-04-17 Novo Nordisk spends billions on share buybacks while forecasting a 5-13% sales decline by 2026. The firm launches…
NNovo Nordisk Read More Dilek Dogan Gurluk, country head, Novo Nordisk – The Irish Times2026-04-17 Dilek Dogan Gurluk, country head of Novo Nordisk, has been chosen as The Irish Times Business Person of…
NNovo Nordisk Read More Novo Nordisk Bets on AI and New Products to Reverse Steep Share Slide2026-04-16 Novo Nordisk shares rebound on UK Wegovy pen approval. The firm combats a weak outlook with an OpenAI…
NNovo Nordisk Read More Novo Nordisk withstands stiff generic competition post semaglutide patent expiry in India in March, 26 brands from 13 firms launched2026-04-16 Danish drug major Novo Nordisk seems to be withstanding stiff competition from generic players after its global blockbuster…
NNovo Nordisk Read More AI and Aggressive Pricing in a Shifting Market2026-04-15 Novo Nordisk slashes US Wegovy HD price to $399/month, partners with OpenAI for AI integration, and faces generic…